NAEVR praises champions for $10 billion funding boon

Article

With the enactment of the American Recovery and Reinvestment Act of 2009 (HR 1) in Denver, the National Alliance for Eye and Vision Research praised Congress and biomedical research champions that facilitated the $10 billion in funding for the National Institutes of Health.

Key Points

Washington, DC-With the enactment of the American Recovery and Reinvestment Act of 2009 (HR 1) in Denver, the National Alliance for Eye and Vision Research (NAEVR) praised Congress and biomedical research champions that facilitated the $10 billion in funding for the National Institutes of Health (NIH).

James Jorkasky, executive director of NAEVR, said, "NAEVR was pleased to support the efforts of Senators Tom Harkin (D-IA), Arlen Specter (R-PA), Richard Durbin (D-IL), and Majority Leader Harry Reid (D-NV) in the Senate, and Speaker Nancy Pelosi (D-CA) and Appropriations Committee Chair David Obey (D-WI) in the House, to include $10 billion in funding for the NIH. We thank them for their commitment to biomedical research and its power to create and sustain jobs through this economic stimulus bill. We also owe a great deal to Maine's Republican Sens. Nancy Collins and Olympia Snowe, who joined with Sen. Specter in demonstrating independence and leadership in ensuring that this measure passed in the Senate."

Jorkasky pointed out that the funding will create 70,000 jobs in the near term and will have an economic impact in every state, as NIH funding trickles down by supporting research at academic institutions nationwide.

Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Prominent legislation includes the Corporate Transparency Act and last year's spending bill provision that was struck down.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.
Steven T. Reed, OD, American Optometric Association's president, overviews the 2024 highlights and how the organization plans to extend success into 2025.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
© 2025 MJH Life Sciences

All rights reserved.